Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Gene therapies for hemophilia hit the mark in clinical trials


Two recent studies describe clinical successes for single-dose gene therapy in trials for two forms of hemophilia.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Gene therapy strategies for hemophilia.

Marina Corral Spence/Springer Nature


  1. Sinsheimer, R.L. Am. Sci. 57, 134–142 (1969).

    CAS  PubMed  Google Scholar 

  2. Mendell, J.R. et al. N. Engl. J. Med. 377, 1713–1722 (2017).

    Article  CAS  Google Scholar 

  3. Rangarajan, S. et al. N. Engl. J. Med. 377, 2519–2530 (2017).

    Article  CAS  Google Scholar 

  4. George, L.A. et al. N. Engl. J. Med. 377, 2215–2227 (2017).

    Article  CAS  Google Scholar 

  5. Srivastava, A. et al. Haemophilia 19, e1–e47 (2013).

    Article  CAS  Google Scholar 

  6. Manno, C.S. et al. Nat. Med. 12, 342–347 (2006).

    Article  CAS  Google Scholar 

  7. Jiang, H. et al. Blood 108, 107–115 (2006).

    Article  CAS  Google Scholar 

  8. McIntosh, J. et al. Blood 121, 3335–3344 (2013).

    Article  CAS  Google Scholar 

  9. Nathwani, A.C. et al. N. Engl. J. Med. 371, 1994–2004 (2014).

    Article  Google Scholar 

  10. Simioni, P. et al. N. Engl. J. Med. 361, 1671–1675 (2009).

    Article  CAS  Google Scholar 

  11. Maheshri, N., Koerber, J.T., Kaspar, B.K. & Schaffer, D.V. Nat. Biotechnol. 24, 198–204 (2006).

    Article  CAS  Google Scholar 

  12. Sharma, R. et al. Blood 126, 1777–1784 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Charles A Gersbach.

Ethics declarations

Competing interests

A.K.P. and C.A.G. are inventors on patent applications related to gene therapy. C.A.G. is a scientific advisor to Sarepta Therapeutics, Locus Biosciences and Element Genomics.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pickar, A., Gersbach, C. Gene therapies for hemophilia hit the mark in clinical trials. Nat Med 24, 121–122 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing